Skip to main content
BiotoxtechCo.,Ltd. logo

BiotoxtechCo.,Ltd. — Investor Relations & Filings

Ticker · 086040 ISIN · KR7086040003 KO Professional, scientific and technical activities
Open in API
Filings indexed 172 across all filing types
Latest filing 2019-03-14 Audit Report / Informat…
Country KR South Korea
Listing KO 086040

About BiotoxtechCo.,Ltd.

http://eng.biotoxtech.com/

Biotoxtech Co., Ltd. is a non-clinical Contract Research Organization (CRO) that provides safety and efficacy evaluation services. The company offers a comprehensive suite of GLP-compliant studies, including general toxicity, carcinogenicity, reproductive and developmental toxicity, genotoxicity, immunotoxicity, and safety pharmacology. It also conducts efficacy evaluations and provides analytical research services such as pharmacokinetics (PK/TK/ADME) and bioanalysis. Biotoxtech serves a diverse clientele developing pharmaceuticals, biomedicines, cell and gene therapies, medical devices, chemicals, agrochemicals, cosmetics, and health functional foods.

Recent filings

Filing Released Lang Actions
감사보고서제출
Audit Report / Information Classification · 1% confidence The document is a formal 'Audit Report Submission' (감사보고서 제출) filed by Biotoxtech. It contains the auditor's opinion (적정/Unqualified), financial highlights (assets, liabilities, equity, revenue, profit), and details regarding the audit firm. While it provides financial data, it is a regulatory disclosure of the audit results rather than the full Annual Report (10-K) or a standalone audit report document. In the context of Korean regulatory filings (DART/KIND), this is classified as an Audit Report/Information filing. FY 2018
2019-03-14 Korean
주주총회소집공고
AGM Information Classification · 1% confidence The document is a formal 'Notice of Annual General Meeting' (주주총회소집공고) for Biotoxtech Co., Ltd. It includes the meeting agenda, details on voting procedures, director candidate information, and management's discussion of business operations and financial statements (consolidated balance sheets, income statements, etc.) for the 19th fiscal year. This is a standard proxy statement and meeting notice package provided to shareholders to solicit votes for the upcoming AGM.
2019-03-07 Korean
주주총회집중일개최사유신고
AGM Information Classification · 1% confidence The document is a formal regulatory filing submitted to the Korea Exchange (KRX) regarding the 'Reason for holding a General Meeting of Shareholders on a concentrated date'. It explains the scheduling constraints for the AGM. Since it is a regulatory disclosure regarding meeting logistics rather than the meeting materials themselves, the proxy statement, or the voting results, it falls under the general regulatory filing category.
2019-02-25 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Audit Report / Information Classification · 1% confidence The document is a regulatory filing from a Korean company (Biotoxtech) disclosing a significant change in revenue or profit structure (30% or more). This type of disclosure is a standard regulatory requirement in the Korean stock market (KRX) for listed companies to provide preliminary financial results before the final audit report is published. It contains key financial highlights, reasons for the change, and a disclaimer that it is pre-audit. This fits the definition of an Earnings Release (ER) as it provides the initial announcement of financial results. FY 2018
2019-02-21 Korean
주주총회소집결의
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) for Biotoxtech. It outlines the date, location, and agenda items (such as approval of financial statements, appointment of directors, and remuneration limits). This type of document is a standard proxy solicitation or notice of meeting sent to shareholders to inform them of upcoming voting matters, which falls under the Proxy Solicitation & Information Statement category.
2019-02-21 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 1% confidence The document is a short regulatory announcement regarding the suspension of share registration (closing of the shareholder register) for the purpose of determining shareholders for an upcoming Annual General Meeting. It does not contain full financial statements or proxy materials, but rather serves as a formal notice of a corporate action. As it does not fit into specific categories like dividend announcements or director dealings, it is classified as a general regulatory filing.
2018-12-12 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.